Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes
Samrat Chakraborty, Zewdu Yilma, Somdyuti Chakraborty, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 20, pp. 34-49
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Targeted therapy for hepatocellular carcinoma: Challenges and opportunities
Shuzhen Chen, Qiqi Cao, Wen Wen, et al.
Cancer Letters (2019) Vol. 460, pp. 1-9
Closed Access | Times Cited: 210
Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy
Zhaoying Fu, Jim Xiang
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9123-9123
Open Access | Times Cited: 151
Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress
Saikat Dewanjee, Pratik Chakraborty, Hiranmoy Bhattacharya, et al.
Free Radical Biology and Medicine (2022) Vol. 193, pp. 134-157
Closed Access | Times Cited: 131
Plant-Based Antidiabetic Nanoformulations: The Emerging Paradigm for Effective Therapy
Saikat Dewanjee, Pratik Chakraborty, Biswajit Mukherjee, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2217-2217
Open Access | Times Cited: 111
Nanoscale bioconjugates: A review of the structural attributes of drug-loaded nanocarrier conjugates for selective cancer therapy
Wenjie Zhang, Reza Taheri‐Ledari, Fatemeh Ganjali, et al.
Heliyon (2022) Vol. 8, Iss. 6, pp. e09577-e09577
Open Access | Times Cited: 55
Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery
Mahavir Narwade, Aazam Shaikh, Kavita R. Gajbhiye, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 40
Recent progress in stimuli-responsive polymeric micelles for targeted delivery of functional nanoparticles
Zhonglin Cao, Xiaoling Zuo, Xiaochen Liu, et al.
Advances in Colloid and Interface Science (2024) Vol. 330, pp. 103206-103206
Closed Access | Times Cited: 14
Apigenin-loaded galactose tailored PLGA nanoparticles: A possible strategy for liver targeting to treat hepatocellular carcinoma
Soumya Ganguly, Saikat Dewanjee, Ramkrishna Sen, et al.
Colloids and Surfaces B Biointerfaces (2021) Vol. 204, pp. 111778-111778
Closed Access | Times Cited: 54
Mapping the gaps in chemical analysis for the characterisation of aptamer-target interactions
Elise Daems, Giulia Moro, Rui Campos, et al.
TrAC Trends in Analytical Chemistry (2021) Vol. 142, pp. 116311-116311
Open Access | Times Cited: 46
Rational design of nanocarriers for mitochondria-targeted drug delivery
Lihua Huang, Zonghao Sun, Qian Shen, et al.
Chinese Chemical Letters (2022) Vol. 33, Iss. 9, pp. 4146-4156
Closed Access | Times Cited: 38
Recent advances in flavonoid-based nanocarriers as an emerging drug delivery approach for cancer chemotherapy
Saikat Dewanjee, Pratik Chakraborty, Hiranmoy Bhattacharya, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 1, pp. 103409-103409
Closed Access | Times Cited: 32
Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives
Janitha M. Unagolla, Subarna Das, Riley Flanagan, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124381-124381
Closed Access | Times Cited: 7
Aptamer-functionalized nanomaterials for biological applications
Qiaoli Ren, Lu Ga, Zhili Lu, et al.
Materials Chemistry Frontiers (2020) Vol. 4, Iss. 6, pp. 1569-1585
Open Access | Times Cited: 40
Emerging nanotaxanes for cancer therapy
Yachao Zhang, Wenjing Zhang, Yongqi Wang, et al.
Biomaterials (2021) Vol. 272, pp. 120790-120790
Closed Access | Times Cited: 34
Phosphorothioated amino-AS1411 aptamer functionalized stealth nanoliposome accelerates bio-therapeutic threshold of apigenin in neoplastic rat liver: a mechanistic approach
Moumita Dhara, Ashique Al Hoque, Ramkrishna Sen, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Nanomedicines for hepatocellular carcinoma therapy: Challenges and clinical applications
Mahsa Sedighi, Zahra Mahmoudi, Samin Abbaszadeh, et al.
Materials Today Communications (2023) Vol. 34, pp. 105242-105242
Open Access | Times Cited: 14
HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma
Chen Shen, Mei Li, Yujuan Duan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment
Debasmita Dutta, Ashique Al Hoque, Brahamacharry Paul, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 5
Cetuximab-conjugated PLGA nanoparticles as a prospective targeting therapeutics for non-small cell lung cancer
Leena Kumari, Iman Ehsan, Arunima Mondal, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 5, pp. 521-536
Open Access | Times Cited: 13
Chemical conjugation of nucleic acid aptamers and synthetic polymers
Maria Nerantzaki, Capucine Loth, Jean‐François Lutz
Polymer Chemistry (2021) Vol. 12, Iss. 24, pp. 3498-3509
Open Access | Times Cited: 26
Potential Health Benefits of Polyphenols and Their Nanoformulations in Humans
Mohd Farhan, Mohammad Aatif
(2025), pp. 367-388
Closed Access
Clofarabine-loaded aptamer-conjugated biodegradable nanoparticle successfully targeted CD117 overexpressed HL60 cells and potentially induced apoptosis
Manisheeta Ray, Ashique Al Hoque, Saptarshi Chatterjee, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42450-e42450
Open Access
Molecular insights into the antineoplastic potential of apigenin and its derivatives: paving the way for nanotherapeutic innovations
Debasmita Dutta, Ashique Al Hoque, Brahamacharry Paul, et al.
Expert Opinion on Drug Delivery (2025)
Closed Access
ΔPSap4#5 surface-functionalized abiraterone-loaded nanoparticle successfully inhibits carcinogen-induced prostate cancer in mice: a mechanistic investigation
Ashique Al Hoque, Debasmita Dutta, Brahamacharry Paul, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Aptamers for the Delivery of Plant-Based Compounds: A Review
Joana Gamboa, Pedro Lourenço, Carla Cruz, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 541-541
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top